The Institute of Molecular Medicine (INFORMM), through its director, Prof Dr Rusli Ismail has invited ARI to participate in a collaborative research.
Specifically, the ARI-INFORMM collaborative research focuses on a study that examines the cost-effectiveness of harm reduction in HIV/AIDS. Though Harm Reduction study is a science-based research, the Accounting Research Institute can contribute significantly by assessing the costs of treatment and to compare those costs with the benefits (or effectiveness) of such treatment. Today, the group met at INFORMM office in USM Penang to discuss details of the project.
Specifically, the ARI-INFORMM collaborative research focuses on a study that examines the cost-effectiveness of harm reduction in HIV/AIDS. Though Harm Reduction study is a science-based research, the Accounting Research Institute can contribute significantly by assessing the costs of treatment and to compare those costs with the benefits (or effectiveness) of such treatment. Today, the group met at INFORMM office in USM Penang to discuss details of the project.
No comments:
Post a Comment